CombiMatrix Ends M&A Talks

The firm has decided to focus on growing its molecular diagnostics services business rather than continuing to pursue a deal with a partner.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories